Search
Search Results
- Author(s):
- Beebe, Albert G., author
- Publication:
- [United States?] : [publisher not identified], [1876?]
- Subject(s):
- Neoplasms -- drug therapy
Homeopathy
- Author(s):
- Ruschenberger, W. S. W. (William Samuel Waithman), 1807-1895, author
- Publication:
- Washington : Government Printing Office, 1873
- Subject(s):
- Neoplasms -- drug therapy
Phytotherapy
Marsdenia
Plant Bark
- Publication:
- Rockville, Md. : Food and Drug Administration, [197-]
- Subject(s):
- Amygdalin -- contraindications
Drug Contamination
Neoplasms -- drug therapy
- Author(s):
- Saules, Carlos Luis de.
- Publication:
- Rio de Janeiro : Typ. Imparcial de Francisco de Paula Brito, 1848
- Subject(s):
- Cecropiaceae
Phytotherapy
Neoplasms -- drug therapy
- Author(s):
- Lewis, Daniel, 1846-1919 author
- Publication:
- [New York?] : [publisher not identified], [1888?]
- Subject(s):
- Neoplasms -- drug therapy
Turpentine -- administration & dosage
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, July 2022
- Subject(s):
- Clinical Trials as Topic
Government Regulation
Neoplasms -- drug therapy
United States
United States. Food and Drug Administration
- Author(s):
- León y Gama, Antonio de, 1735-1802
- Publication:
- En Mexico : Por D. Felipe de Zúñiga y Ontiveros ..., 1783
- Subject(s):
- Neoplasms -- drug therapy
Salamandridae
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, March 2019
- Subject(s):
- Clinical Trials as Topic -- ethics
Adolescent
Neoplasms -- drug therapy
Adult
Medical Oncology -- ethics
Patient Safety
Patient Selection
Pharmacokinetics
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, March 2019
- Subject(s):
- Clinical Trials as Topic
Prognosis
Research Design
Biomarkers, Pharmacological
Biomarkers, Tumor
Captopril -- therapeutic use
Cardiovascular Diseases -- drug therapy
Clozapine -- therapeutic use
Cyclooxygenase 2 Inhibitors -- therapeutic use
Drugs, Investigational
Lung Diseases -- drug therapy
Medication Adherence
Neoplasms -- drug therapy
Patient Compliance
Patient Selection
Pharmacogenetics
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, May 2019
- Subject(s):
- Antineoplastic Agents -- adverse effects
Mutagenicity Tests -- standards
Neoplasms -- drug therapy
Reproduction -- drug effects
Teratogens
Toxicity Tests -- standards
Contraception
Drug-Related Side Effects and Adverse Reactions
Fertility
Geriatrics
Pediatrics
Postmenopause
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
